TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive Stand Up To Cancer Selects Five Groups For “Dream Team” Grants Totaling $73.6M. May 29, 2009
TCL Archive Children’s Oncology Group to Select New Chairman; Four Leaders to Step Aside April 28, 2000
